buchspektrum Internet-Buchhandlung

Neuerscheinungen 2011

Stand: 2020-01-07
Schnellsuche
ISBN/Stichwort/Autor
Herderstraße 10
10625 Berlin
Tel.: 030 315 714 16
Fax 030 315 714 14
info@buchspektrum.de

Enikö Kokai

C-Myc expression in adult and embryonic endothelial cells


C-Myc is essencial for adequate vasculogenesis and angiogenesis
2011. 136 S. 220 mm
Verlag/Jahr: SÜDWESTDEUTSCHER VERLAG FÜR HOCHSCHULSCHRIFTEN 2011
ISBN: 3-8381-2425-1 (3838124251)
Neue ISBN: 978-3-8381-2425-4 (9783838124254)

Preis und Lieferzeit: Bitte klicken


It was shown that c-Myc is required for adequate vasculogenesis and angiogenesis. To investigate the contribution of Myc to these processes, we conditionally expressed c-Myc in adult and embryonic endothelial cells. C-Myc expression in adult endothelial cells induced the development of angiosarcomas and/or adenomas. Double transgenic mice died in average with 36 weeks. Inactivation of the transgene system in vivo results in partial tumor regression. C-Myc expressing embryos suffer from widespread edema formation and hemorrhagic lesions. They die between embryonic day (E) E14.5 and E17.5. The changes in vascular permeability are not caused by defects in vascular basement membrane composition or pericyte coverage. Alterations in the architecture of capillary networks were found. Endothelial cells show increased levels of both proliferation and apoptosis. The dermal vasculature of C-Myc expressing embryos show a reduction in vessel branching, which occurs despite up-regulation of the pro-angiogenic factors VEGF-A and angiopoietin-2 (Ang-2). Thus, the net outcome of an excess of VEGF-A and Ang-2 in the face of an elevated cellular turnover appears to be a defect in vascular integrity.
Enikö Kokai finished her study at the Budapest University ofTechnology and Economics as biology engineer. She continuedher education in the field of molecular biology at the Instituteof Physiological Chemistry at the Ulm University. She isinterested particularly in the field of blood vessel formationunder tumorigenic conditions.